Does UPADACITINIB Cause Intervertebral disc degeneration? 142 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Intervertebral disc degeneration have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
142
Reports of Intervertebral disc degeneration with UPADACITINIB
0.2%
of all UPADACITINIB reports
0
Deaths
57
Hospitalizations
How Dangerous Is Intervertebral disc degeneration From UPADACITINIB?
Of the 142 reports, 57 (40.1%) required hospitalization.
Is Intervertebral disc degeneration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 142 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Intervertebral disc degeneration?
ADALIMUMAB (873)
ALENDRONATE (339)
ETANERCEPT (311)
METHOTREXATE (308)
EMTRICITABINE\TENOFOVIR DISOPROXIL (210)
PREGABALIN (204)
PREDNISONE (202)
RITUXIMAB (200)
OXYCODONE (184)
SODIUM OXYBATE (178)
Which UPADACITINIB Alternatives Have Lower Intervertebral disc degeneration Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL